As observed with Leukemia, the number of mortality cases are estimated to increase at a higher rate than the number of newly diagnosed cases (+62% vs. +41%) in the APAC 11 countries.
0 Comments
The higher estimated percentage increase in the mortality cases compared to the newly diagnosed cases (49% vs. 34%) in the APAC 11 countries indicates the need for strengthening healthcare paradigm in the region. Brand Performance Study for a European Vaccine Company |
 | A leading European vaccine company launched its newly developed vaccine in the APAC region. Read more to learn how we helped our client in tracking overall brand performance in Singapore, Malaysia, and Thailand. |
 | March is the month for Colorectal cancer awareness. We present here an infographic comparing the incidence and mortality data of Colorectal cancer in the APAC vs RoW. Read more to check the statistics. |
By 2040, CRC incidence is estimated to increase in APAC 11 countries by 73% to approx. 1.2 million. Unfortunately, the mortality related disease burden is expected to be doubled by the year 2040.
Bile Duct Cancer Awareness Month - QnA Session with an Expert
(Focus: Malaysia)
Dr. Tang Weng Heng is a leading Clinical Oncologist in Malaysia. We would like to thank him for taking out time from his busy schedule to share with us his thoughts and experiences on diagnosis, treatment and management of bile duct cancer. We hope this interview will help our readers in understanding this rare but highly aggressive cancer.
Product Concept Testing Study for a Global Pharma Company
(Focus: Thailand)
 | A global pharmaceutical company wanted to promote their novel fixed dose combination diabetes pill in the Thailand market. Read more to learn how Oncofocus helped client in understanding the initial impressions of the physicians and assess the market preferences. |
 | February is the designated month for spreading awareness on Gall Bladder cancer. We present an infographic comparing the incidence and mortality data of Gall Bladder in the APAC vs RoW. |
When compared to the Rest of the World, a clear spike (>30%) in the mortality related disease burden is expected in the APAC 11 by the year 2040.
Cervical Cancer Screening Awareness Survey (Focus: US)
The recent report in 2018 by the US Preventive Services Task Force (USPSTF) shows that the cervical cancer related mortality has substantially decreased due to screening programmes. The report mentions that number of deaths have declined from 2.8 to 2.3 per 100,000 women from 2000 to 2015.
We did an online survey in this month in the US to understand following -
- do educated adult (18 years or above) Americans, who are aware about Cervical cancer, themselves go (in case of female) OR take their family members for regular screening (in case of both male and female)?
- what are the key reasons behind not going for the voluntary screening?
Cervical Cancer Awareness Month - QnA Session with an Expert (2/2)
(Focus: Malaysia)
For our second Cervical cancer interview, we discussed with Dr. Lim Chun Sen, a leading Malaysian Oncologist, his experience in treating Cervical cancer patients, challenges with diagnosis, and key future trends in Cervical cancer screening and management.
Dr. Lim Chun Sen is a Clinical Oncologist since 2014 and is presently managing the department of Oncology in Hospital Sultan Ismail, Malaysia.
Dr. Lim Chun Sen is a Clinical Oncologist since 2014 and is presently managing the department of Oncology in Hospital Sultan Ismail, Malaysia.
Cervical Cancer Awareness Month - QnA Session with an Expert (1/2)
(Focus: India)
January is designated for raising awareness on Cervical cancer. We interviewed Dr. Rahul Roy Chowdhury, a leading Oncologist, to understand the current practice, challenges, and future trends in Cervical cancer screening and management.
Dr. Rahul Roy Chowdhury has been practicing as a Gynecological Oncologist for several years, following his training in the United Kingdom as a Gynecologist and an Oncologist. Along with his practice, he is involved in multiple clinical trials and is keenly interested in research activities.
Dr. Rahul Roy Chowdhury has been practicing as a Gynecological Oncologist for several years, following his training in the United Kingdom as a Gynecologist and an Oncologist. Along with his practice, he is involved in multiple clinical trials and is keenly interested in research activities.
